E-LIB Suche - Ergebnisse für: Sharfman, William H.

1

Nivolumab with or without ipilimumab in patients with recur..:

Oaknin, Ana ; Moore, Kathleen ; Meyer, Tim...
The Lancet Oncology. 25 (2024) 5 - p. 588-602 , 2024

Link: https://doi.org/10.1016/..

2

Bing‐Neel syndrome:

Davis, Katelynn ; Sharfman, William H. ; Francischetti, Ivo M. B.
eJHaem. 3 (2022) 4 - p. 1425-1426 , 2022

Link: https://doi.org/10.1002/..

3

An Open–Label, Randomized, Multi–Center Study Comparing the..:

Hasanov, Merve ; Milton, Denái R. ; Sharfman, William H....
OncoImmunology. 10 (2021) 1 - p. , 2021

Link: https://doi.org/10.1080/..

4

Three-year survival, correlates and salvage therapies in pa..:

Nghiem, Paul ; Bhatia, Shailender ; Lipson, Evan J...
Journal for ImmunoTherapy of Cancer. 9 (2021) 4 - p. e002478 , 2021

Link: https://doi.org/10.1136/..

5

Rescue therapy for patients with anti-PD-1-refractory Merke..:

LoPiccolo, Jaclyn ; Schollenberger, Megan D. ; Dakhil, Sumia...
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

6

Immune-related adverse events with immune checkpoint inhibi..:

Moseley, Kendall F. ; Naidoo, Jarushka ; Bingham, Clifton O....
Journal for ImmunoTherapy of Cancer. 6 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

7

From validity to clinical utility: the influence of circula..:

Rowe, Steven P. ; Luber, Brandon ; Makell, Monique...
Molecular Oncology. 12 (2018) 10 - p. 1661-1672 , 2018

Link: https://doi.org/10.1002/..

8

Inflammatory Arthritis: A Newly Recognized Adverse Event of..:

Naidoo, Jarushka ; Cappelli, Laura C. ; Forde, Patrick M....
The Oncologist. 22 (2017) 6 - p. 627-630 , 2017

Link: https://doi.org/10.1634/..

9

BRAF‐V600 mutational status affects recurrence patterns of ..:

Maxwell, Russell ; Garzon‐Muvdi, Tomas ; Lipson, Evan J....
International Journal of Cancer. 140 (2017) 12 - p. 2716-2727 , 2017

Link: https://doi.org/10.1002/..

10

Tumor and Microenvironment Evolution during Immunotherapy w..:

Riaz, Nadeem ; Havel, Jonathan J. ; Makarov, Vladimir...
Cell. 171 (2017) 4 - p. 934-949.e16 , 2017

Link: https://doi.org/10.1016/..

11

Safety and immunologic correlates of Melanoma GVAX, a GM-CS..:

Lipson, Evan J ; Sharfman, William H ; Chen, Shuming...
Journal of Translational Medicine. 13 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

12

Primary Small Cell Neuroendocrine Carcinoma of Paranasal Si..:

Khan, Maliha ; Nizami, Sobia ; Mirrakhimov, Aibek E....
Case Reports in Medicine. 2014 (2014) - p. 1-4 , 2014

Link: https://doi.org/10.1155/..

13

Head and Neck Cutaneous Melanoma: A 2012 Update:

Schmalbach, Cecelia E. ; Bradford, Carol R. ; Myers, Jeffrey N....
Otolaryngology–Head and Neck Surgery. 147 (2012) S2 - p. , 2012

Link: https://doi.org/10.1177/..

14

A new American Joint Committee on Cancer staging system for..:

Farasat, Sharifeh ; Yu, Siegrid S. ; Neel, Victor A....
Journal of the American Academy of Dermatology. 64 (2011) 6 - p. 1051-1059 , 2011

Link: https://doi.org/10.1016/..

15

Has the analgesic efficacy of neurolytic celiac plexus bloc..:

Sharfman, William H. ; Walsh, Declan T.
Pain. 41 (1990) 3 - p. 267-271 , 1990

Link: https://doi.org/10.1016/..